| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 7,000 | $19.39 | $135,697.35 | -0.4% | -12.0% | - | |
| Sep 19, 2025 | Kintz Samuel51 | President And CEO | Sell | 6,000 | $19.29 | $115,723.00 | -0.3% | -12.0% | - | |
| Sep 8, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $20.24 | $134,957.41 | -2.3% | +2.5% | - | |
| Aug 27, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $20.63 | $67,038.73 | -12.4% | +4.9% | - | |
| Aug 21, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,500 | $19.86 | $248,216.50 | -0.7% | +11.4% | - | |
| Aug 19, 2025 | Kintz Samuel51 | President And CEO | Sell | 10,983 | $20.02 | $219,906.31 | -0.6% | +10.1% | - | |
| Aug 7, 2025 | Patel Anish54 | Chief Operating Officer | Sell | 6,667 | $18.24 | $121,615.52 | -1.1% | +3.4% | - | |
| Jul 28, 2025 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $20.46 | $66,503.76 | -6.6% | +3.5% | - | |
| Jul 21, 2025 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,500 | $22.29 | $278,645.80 | -0.7% | +1.1% | - | |
| Jul 17, 2025 | Kintz Samuel51 | President And CEO | Sell | 12,500 | $22.52 | $281,517.86 | -0.4% | -6.9% | - |